Filters
Sort results
Reset
Apply
Cat No. | Products Name | Name | Previous Name | Target | Format | Options | Order | quote |
|---|---|---|---|---|---|---|---|---|
Pre-Made Alnuctamab biosimilar, Bispecific mAb with Domain Crossover, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody |
Alnuctamab |
NA |
TNFRSF17,CD3E |
Bispecific mAb with Domain Crossover |
||||
Pre-Made Belantamab biosimilar, Whole mAb ADC, Anti-TNFRSF17 Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A therapeutic antibody |
Belantamab |
NA |
TNFRSF17 |
Whole mAb ADC |
||||
Pre-Made Pacanalotamab biosimilar, Bispecific scFv, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody |
Pacanalotamab |
NA |
TNFRSF17,CD3E |
Bispecific scFv |
||||
Pre-Made Pavurutamab biosimilar, Bispecific scFv, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody |
Pavurutamab |
NA |
TNFRSF17,CD3E |
Bispecific scFv |
||||
Pre-Made Teclistamab biosimilar, Bispecific mAb, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody |
Teclistamab |
NA |
TNFRSF17,CD3E |
Bispecific mAb |
||||
Pre-Made Elranatamab biosimilar, Whole mAb, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody |
Elranatamab |
NA |
TNFRSF17,CD3E |
Bispecific Whole mAb |
||||
Pre-Made Belantamab Mafodotin Biosimilar, Whole Mab Adc, Anti-Tnfrsf17 Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A therapeutic antibody Drug Conjugate |
belantamab mafodotin |
NA |
TNFRSF17 |
Whole mAb ADC |
